An Immune-Inflammation Gene Expression Signature in Prostate Tumors of Smokers
Robyn L. Prueitt(Gradient (United States)), Stefan Ambs(University of Maryland, Baltimore), James F. Borin, Nagireddy Putluri(Baylor College of Medicine), Robert Hudson(National Cancer Institute), Sharon A. Glynn(Ollscoil na Gaillimhe – University of Galway), Jennifer L. Shoe(Leidos (United States)), Wei Tang(Agency for Science, Technology and Research), Arun Sreekumar(University of Michigan–Ann Arbor), Atsushi Terunuma(Yotsuya Medical Cube), Harris G. Yfantis(University of Maryland, Baltimore), Diana C. Haines(Leidos (United States)), Tiffany H. Dorsey(Center for Cancer Research), Michael J. Naslund(University of Maryland, Baltimore), Jun Luo(Johns Hopkins University), Tiffany A. Wallace(University of Florida), Christopher A. Loffredo(Georgetown University), Ming Yi(Science Applications International Corporation (United States)), Robert M. Stephens(National Cancer Institute), John W. Gillespie(National Cancer Institute), Misop Han(Johns Hopkins University), Richard B. Alexander, Symone V. Jordan(Center for Cancer Research), Arthur A. Hurwitz(SUNY Upstate Medical University), Katherine E. Stagliano(National Institutes of Health), Dong Hoon Lee(Korea University), Damali N. Martin(National Institutes of Health)
Cited by 43
Related Papers
A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus
|Nature Genetics|2013|922
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
|Nature|2017|853
Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer
|Cancer Research|2008|708
Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer
|Nature Medicine|2009|666